Correlation Between Nutriband Warrant and Virax Biolabs

Can any of the company-specific risk be diversified away by investing in both Nutriband Warrant and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutriband Warrant and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nutriband Warrant and Virax Biolabs Group, you can compare the effects of market volatilities on Nutriband Warrant and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutriband Warrant with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutriband Warrant and Virax Biolabs.

Diversification Opportunities for Nutriband Warrant and Virax Biolabs

-0.27

Correlation Coefficient

Nutriband Warrant  Virax Biolabs

Very good diversification

The 3 months correlation between Nutriband and Virax is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Nutriband Warrant and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Nutriband Warrant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutriband Warrant are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Nutriband Warrant i.e., Nutriband Warrant and Virax Biolabs go up and down completely randomly.

Pair Corralation between Nutriband Warrant and Virax Biolabs

Assuming the 90 days horizon Nutriband Warrant is expected to under-perform the Virax Biolabs. But the stock apears to be less risky and, when comparing its historical volatility, Nutriband Warrant is 1.69 times less risky than Virax Biolabs. The stock trades about -0.07 of its potential returns per unit of risk. The Virax Biolabs Group is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  188.00  in Virax Biolabs Group on September 21, 2024 and sell it today you would earn a total of  1.00  from holding Virax Biolabs Group or generate 0.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Nutriband Warrant  vs.  Virax Biolabs Group

Nutriband Warrant

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Nutriband Warrant are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Nutriband Warrant showed solid returns over the last few months and may actually be approaching a breakup point.

Virax Biolabs Group

Risk-Adjusted Performance

1 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Virax Biolabs Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Virax Biolabs showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nutriband Warrant and Virax Biolabs

The main advantage of trading using opposite Nutriband Warrant and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutriband Warrant position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.

The idea behind Nutriband Warrant and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.